The 2023 ACR/EULAR classification criteria of CPPD [14]
Criteria | |
---|---|
Entry criterion | |
- Ever had at least one episode of joint pain, swelling, or tenderness (in a peripheral joint or axial joint such as C1/C2 in the case of crowned dens syndrome). | |
Absolute exclusion criteria | |
- All symptoms more likely explained by an alternate condition (e.g., rheumatoid arthritis, gout, psoriatic arthritis, OA, etc.). | |
Sufficient criteria | |
- Crowned dens syndrome (as characterized by both clinical and imaging features).- Synovial fluid analysis demonstrating CPP crystals in a joint with swelling, tenderness or pain. | |
Additional classifications | |
- An individual is classified as CPPD if the entry criterion is met, exclusion criteria are not met, and at least one sufficient criterion is fulfilled.- If none of the sufficient criteria are present, an individual is classified as CPPD disease if the sum of the criteria below is > 56 points. | |
Scoring guidelines | |
- Items can be scored if they were ever present during a patient’s lifetime.- If a patient fulfills > 1 item in a given domain, only the highest weighted item will be scored.- Imaging of at least one symptomatic joint by CR, US, CT, or DECT is required. | |
Domains and levels | Points |
A. Age at onset of joint symptoms | |
≤ 60 years | 0 |
> 60 years | 4 |
B. Time-course and symptoms of inflammatory arthritis | |
No persistent or typical inflammatory arthritis | 0 |
Persistent inflammatory arthritis (ongoing joint swelling with pain and/or warmth in one or more joints) | 9 |
1 typical acute arthritis episode (episode with acute onset or acute worsening of joint pain with swelling and/or warmth that resolves regardless of treatment) | 12 |
More than 1 typical acute arthritis episode | 16 |
C. Sites of typical episode(s) of inflammatory arthritis in peripheral joints | |
1st MTPJ | -6 |
No typical episode(s) | 0 |
Joint(s) other than wrist, knee, or 1st MTPJ | 5 |
Wrist | 8 |
Knee | 9 |
D. Related metabolic diseases (hereditary hemochromatosis, primary hyperparathyroidism, hypomagnesemia, Gitelman syndrome, hypophosphatasia, or a familial history of CPPD disease) | |
None | 0 |
Present | 6 |
E. Synovial fluid crystal analysis from a symptomatic joint | |
CPP crystals absent on ≥ 2 occasions | –7 |
CPP crystals absent on 1 occasion | –1 |
Not performed | 0 |
F. OA of hand/wrist on imaging | |
None of the following findings or no wrist/hand imaging performed | 0 |
Bilateral radio-carpal joints | 2 |
≥ 2 of the following: STTJ OA without 1st CMCJ OA; 2nd MCPJ OA; 3rd MCPJ OA | 7 |
G. Imaging evidence of CPPD in symptomatic peripheral joint(s) | |
None on US, CT, or DECT (and absent on CR or CR not performed) | –4 |
None on CR (and US, CT, DECT not performed) | 0 |
Present on either CR, US, CT, or DECT | 16 |
H. Number of peripheral joints with evidence of CPPD on any imaging modality | |
None | 0 |
1 | 16 |
2–3 | 23 |
≥ 4 | 25 |
ACR: American College of Rheumatology; EULAR: European League Against Rheumatism; CPPD: calcium pyrophosphate deposition disease; CPP: calcium pyrophosphate; CR: conventional X-ray radiography; US: ultrasound; CT: computed tomography; DECT: dual-energy computed tomography; MTPJ: metatarsophalangeal joint; OA: osteoarthritis; STTJ: scaphotrapeziotrapezoid joint; CMCJ: carpometacarpal joint; MCPJ: metacarpophalangeal joint
Note. Adapted with permission from “The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease” by Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, et al. Ann Rheum Dis. 2023;82:1248–57 (https://ard.bmj.com/content/82/10/1248). © Author(s) (or their employer(s)) 2023.